A new β-tricalcium phosphate with uniform triple superporous structure as a filling material after curettage of bone tumor.

Background: A new β-tricalcium phosphate with uniform triple superpore structure, SuperPore(®) (HOYA, Tokyo, Japan), has been in clinical use since 2010. As far as we are aware of, there have been no reported clinical studies using this material. We report on the first clinical cases of benign bone tumor filled with SuperPore(®).